CLOV vs HAE
Clover Health Investments Corp (CLOV) versus Haemonetics Corporation (HAE) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
CLOV currently screens at market cap $1.55B. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Not investment advice. Open the CLOV and HAE stock pages for the full models.
Not investment advice.